As of day 2 end, Nexus IPO is fully subscribed in non-institutional category (note- there are only 2 categories in these kind of IPOs,insti and non-insti)…overall subscription stands at 57% at the end of day 2.
Full allotment in non-insti category is ruled out, given the over subscription.
PS – Grey market premium is Rs 5 only. But, if there is one lesson from Mankind pharma ipo, subscription % can’t be equated to listing gains. That said, this is a different kind of instrument (REIT vs equity) and no point comparing. A pop in listing is unexpected in these instruments, unless one gets into a phase of Euphoric Embassy type of post listing phase. The yields and the comparison with GSec won’t justify that
| Subscribe To Our Free Newsletter |
